Clinical Studies on XTRAC
XTRAC has been cited on over 45 clinical studies and research programs
with findings published in peer-reviewed medical journals around the world. Two specific studies about XTRAC:
Efficacy of the 308-nm excimer laser for treatment of psoriasis:
Results of a multicenter study
From the Departments of Dermatology and Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem; Dermatology Associates, Encinitasc; Laser and Skin Surgery Center of New York, New York City; Lehigh Valley Dermatology, Bethlehem; and Johns Hopkins at Green Spring, Lutherville.
Published by the American Academy of Dermatology
Of patients meeting clinical study protocol requirements:
- 84% reached improvement of 75% or better after 10 or fewer treatments
- 50% reached improvement of 90% or better after 10 or fewer treatments
"The XTRAC appears to have considerable advantages over other available treatment modalities for psoriasis, including fewer treatments to achieve results, and the added safety of site-specific dosing without exposure to healthy skin. In addition, this study has shown the XTRAC to be well tolerated and effective in treating thick, scaled plaques on the knees and elbows, which are often resistant to treatment."
Click to download full study
Effective treatment of scalp psoriasis using the excimer (308nm) laser From Johns Hopkins at Green Spring Station
Published by the Journal of Photodermatology, Photoimmunology & Photomedicine
"The XTRAC is a successful approach to treatment of psoriasis of the scalp in that it is a simple treatment that can be performed in a short period of time and which has a high rate of effectiveness. All patients in the study noticed improvement in their scalp psoriasis and 49% of the patients obtained a greater than 95% improvement."
Click to download full study